During the past decade, New England Center for Clinical Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 13 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New England Center for Clinical Research" #1 sponsor was "Purdue Pharma LP" with 6 trials, followed by "Pfizer" with 4 trials sponsored, "BioCryst Pharmaceuticals" with 3 trials sponsored, "Novartis" with 2 trials sponsored and "Zogenix, Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New England Center for Clinical Research" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "The Cleveland Clinic" with 1 trials as a collaborator and "VertiFlex, Incorporated" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "New England Center for Clinical Research" are "Low Back Pain" (5 trials), "Back Pain Lower Back Chronic" (3 trials), "Chronic Pain" (3 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Influenza" (2 trials). Many other conditions were trialed in "New England Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "New England Center for Clinical Research" are "Drug" (22 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Naproxen" (3 trials), "Buprenorphine" (2 trials), "Buprenorphine transdermal patch" (2 trials) and "Peramivir" (2 trials). Other intervention names were less common.

The vast majority of trials in "New England Center for Clinical Research" are 24 trials for "All" genders.

Currently, there are NaN active trials in "New England Center for Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in New England Center for Clinical Research, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in New England Center for Clinical Research, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".